Table 1.
Prevalence of depression, anxiety, and alexithymia at baseline (T0), within one-week post-intervention (T4), and at 18 months post-intervention (T5).
Prevalence changes |
||||||||
---|---|---|---|---|---|---|---|---|
Comparisons between T0 and T4 (N = 27) |
Comparisons between T0 and T5 (N = 15) |
|||||||
T0 | T4 | Prevalence changes | p a | T0 | T5 | Prevalence changes | p a | |
Depression (HADS-D ≥ 8 p) | 16 (59) | 7 (26) | −33% | .004 | 10 (67) | 4 (27) | −40% | .031 |
Anxiety (HADS-A ≥ 8 p) | 23 (85) | 13 (48) | −37% | .006 | 12 (80) | 9 (60) | −20% | .45 |
Alexithymia (TAS-20 ≥ 61 p) | 9 (33) | 3 (11) | −22% | .070 | 3 (20) | 0 (0) | −20% | .25 |
Data are presented as N (%).
McNemar test.